FOI release

Vancomycin information

Some or all of the information requested may not have been provided because we determined that the request was vexatious.

Case reference FOI2026/00010

Received 6 January 2026

Published 25 February 2026

Request

We wish to request copies of the latest approved Clinical / Non-Clinical / Quality overviews from the following licences: • Vancomycin Morningside Healthcare, 125mg, Capsules, hard, PL 20117/0149 • Vancomycin Wockhardt UK, 500 mg and 1 g, Powder for solution for intravenous infusion / Powder for solution for oral use, PL 29831/0319 and PL 29831/0322

Response

See attached

Documents

• FOI2026_00010 (redacted).pdf (688.0 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.